Literature DB >> 11404432

Morphine-induced dependence and sensitization are altered in mice deficient in AMPA-type glutamate receptor-A subunits.

O Y Vekovischeva1, D Zamanillo, O Echenko, T Seppälä, M Uusi-Oukari, A Honkanen, P H Seeburg, R Sprengel, E R Korpi.   

Abstract

AMPA-type glutamate receptors have been suggested to be involved in the neurobiological mechanisms of drug addiction. We have made use of two mouse lines, which both have modulated AMPA receptor responses. The first line is entirely deficient in glutamate receptor-A (GluR-A) subunits (A-/- knock-out line) and, in the second one, the Q582 residue of GluR-A subunits is replaced by an arginine residue (R/R mutants), which reduces the calcium permeability and channel conductance of the receptors containing this mutated subunit. Mice of both lines are healthy, but they show slightly increased locomotor activity. Acute morphine administration enhanced locomotor activity of the GluR-A-/- and GluR-A(R/R) mice, at least as much as that of their wild-type littermates. Only in the GluR-A-/- mice did we observe reduced tolerance development in tail-flick antinociception and less severe naloxone-precipitated withdrawal symptoms after treatment with increasing morphine doses, without differences in plasma and brain morphine levels when compared with wild type. Repeated daily morphine administration sensitized the locomotor activity responses in the GluR-A-/- and GluR-A(R/R) mice only when given in the measuring cages, whereas the wild-type mice showed slightly increased responses also when the repeated treatment was given in their home cages. Normal or even enhanced context-dependent sensitization was observed also with repeated amphetamine administration in the GluR-A subunit-deficient mice. The results indicate that AMPA receptors are involved in the acute and chronic effects of morphine, including context-independent sensitization, and that the GluR-A subunit itself is important for morphine tolerance and dependence.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11404432      PMCID: PMC6762742     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  47 in total

Review 1.  Addiction, dopamine, and the molecular mechanisms of memory.

Authors:  J D Berke; S E Hyman
Journal:  Neuron       Date:  2000-03       Impact factor: 17.173

Review 2.  Genes and addiction.

Authors:  E J Nestler
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

3.  Glutamate-operated channels: developmentally early and mature forms arise by alternative splicing.

Authors:  H Monyer; P H Seeburg; W Wisden
Journal:  Neuron       Date:  1991-05       Impact factor: 17.173

4.  Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting.

Authors:  H Gu; Y R Zou; K Rajewsky
Journal:  Cell       Date:  1993-06-18       Impact factor: 41.582

5.  AMPA antagonist LY293558 blocks the development, without blocking the expression, of behavioral sensitization to morphine.

Authors:  W A Carlezon; K Rasmussen; E J Nestler
Journal:  Synapse       Date:  1999-03-15       Impact factor: 2.562

6.  Morphine alters the structure of neurons in the nucleus accumbens and neocortex of rats.

Authors:  T E Robinson; B Kolb
Journal:  Synapse       Date:  1999-08       Impact factor: 2.562

7.  Dysfunctions in mice by NMDA receptor point mutations NR1(N598Q) and NR1(N598R).

Authors:  F N Single; A Rozov; N Burnashev; F Zimmermann; D F Hanley; D Forrest; T Curran; V Jensen; O Hvalby; R Sprengel; P H Seeburg
Journal:  J Neurosci       Date:  2000-04-01       Impact factor: 6.167

8.  Effects of the AMPA receptor antagonist NBQX on the development and expression of behavioral sensitization to cocaine and amphetamine.

Authors:  Y Li; A J Vartanian; F J White; C J Xue; M E Wolf
Journal:  Psychopharmacology (Berl)       Date:  1997-12       Impact factor: 4.530

9.  AMPA-receptors are involved in the expression of amphetamine-induced behavioural sensitisation, but not in the expression of amphetamine-induced conditioned activity in mice.

Authors:  A N Mead; D N Stephens
Journal:  Neuropharmacology       Date:  1998-09       Impact factor: 5.250

10.  Sensitive and rapid behavioral differentiation of N-methyl-D-aspartate receptor antagonists.

Authors:  M J Ginski; J M Witkin
Journal:  Psychopharmacology (Berl)       Date:  1994-05       Impact factor: 4.530

View more
  25 in total

Review 1.  Candidate gene polymorphisms predicting individual sensitivity to opioids.

Authors:  Shinya Kasai; Masakazu Hayashida; Ichiro Sora; Kazutaka Ikeda
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-11-13       Impact factor: 3.000

2.  Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal.

Authors:  Liting Deng; Josée Guindon; Benjamin L Cornett; Alexandros Makriyannis; Ken Mackie; Andrea G Hohmann
Journal:  Biol Psychiatry       Date:  2014-04-25       Impact factor: 13.382

3.  Mu-opioid receptors modulate the stability of dendritic spines.

Authors:  Dezhi Liao; Hang Lin; Ping Yee Law; Horace H Loh
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-19       Impact factor: 11.205

4.  The effects of AMPA receptor blockade in the prelimbic cortex on systemic and ventral tegmental area opiate reward sensitivity.

Authors:  Xavier De Jaeger; Stephanie F Bishop; Tasha Ahmad; Danika Lyons; Garye Ami Ng; Steven R Laviolette
Journal:  Psychopharmacology (Berl)       Date:  2012-09-13       Impact factor: 4.530

5.  AMPA receptor positive allosteric modulators attenuate morphine tolerance and dependence.

Authors:  Xiaoyu Hu; Xuebi Tian; Xiao Guo; Ying He; Haijun Chen; Jia Zhou; Zaijie Jim Wang
Journal:  Neuropharmacology       Date:  2018-04-25       Impact factor: 5.250

6.  Selective disruption of stimulus-reward learning in glutamate receptor gria1 knock-out mice.

Authors:  Andy N Mead; David N Stephens
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

7.  Acute and chronic heroin dependence in mice: contribution of opioid and excitatory amino acid receptors.

Authors:  Gad Klein; Aaron Juni; Caroline A Arout; Amanda R Waxman; Charles E Inturrisi; Benjamin Kest
Journal:  Eur J Pharmacol       Date:  2008-02-19       Impact factor: 4.432

Review 8.  Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis.

Authors:  William A Carlezon; Mark J Thomas
Journal:  Neuropharmacology       Date:  2008-07-15       Impact factor: 5.250

9.  Increased AMPA receptor GluR1 subunit incorporation in rat hippocampal CA1 synapses during benzodiazepine withdrawal.

Authors:  Paromita Das; Scott M Lilly; Ricardo Zerda; William T Gunning; Francisco J Alvarez; Elizabeth I Tietz
Journal:  J Comp Neurol       Date:  2008-12-20       Impact factor: 3.215

10.  Cocaine-induced potentiation of synaptic strength in dopamine neurons: behavioral correlates in GluRA(-/-) mice.

Authors:  Y Dong; D Saal; M Thomas; R Faust; A Bonci; T Robinson; R C Malenka
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.